Pharmaceutical Secondary Packaging Industry Projected US$ 72,010 Million by 2032: In Depth Research Report

The Pharmaceutical Secondary Packaging Industry is a specialized sector within the pharmaceutical and healthcare industry that focuses on the packaging of pharmaceutical products at the secondary packaging stage. Secondary packaging is the packaging process that follows primary packaging (the immediate packaging of the pharmaceutical product, such as blister packs or vials) and precedes tertiary packaging (the packaging used for bulk shipping and distribution).

The Pharmaceutical Secondary Packaging Industry is expected to be worth US$ 41,950 million in 2023, rising to US$ 72,010 million by 2032. Revenue from pharmaceutical secondary packaging sales is predicted to grow at a CAGR of 6.2% during the forecast period.

The increasing demand for child-resistant and senior-friendly packaging is also driving the growth of the industry. These packaging options are designed to prevent accidental ingestion of drugs by children and older adults. This helps to improve patient safety and reduce the risk of medication errors. Additionally, the growing number of prescription drugs is driving the revenue growth from the sales

The pharmaceutical secondary packaging industry is witnessing significant growth, driven by various factors such as the increasing use of unit dose packaging for drugs, the growing importance of product safety and traceability, and the increasing use of child-resistant and senior-friendly packaging. The rise in Unit Dose Packaging is one of the key drivers of the industry.

Get an Exclusive Sample Copy of the Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16614

Market Dynamics and Trends:

1. Increased Automation: The pharmaceutical industry is witnessing an increased adoption of automation in secondary packaging processes. Automated systems enhance efficiency, reduce errors, and improve overall productivity.
2. Sustainability: There is a growing emphasis on sustainable packaging solutions in the pharmaceutical industry, including secondary packaging. Manufacturers are exploring environmentally friendly materials and designs to reduce the environmental impact of packaging.
3. Personalized Medicine Packaging: As the trend toward personalized medicine grows, secondary packaging may need to adapt to accommodate smaller batch sizes and unique product configurations.
4. Regulatory Changes: Evolving regulatory landscapes, including serialization requirements and anti-counterfeiting measures, influence the design and implementation of pharmaceutical secondary packaging.
5. Integration of Smart Packaging: The integration of smart packaging technologies, such as RFID (Radio-Frequency Identification) and NFC (Near Field Communication), is gaining traction. These technologies offer real-time tracking and monitoring capabilities.

Key Takeaways from the Pharmaceutical Secondary Packaging Industry

• The market in Canada is expected to grow at a 6.3% CAGR during the forecast period, reaching US$ 4,085 million by 2032.
• The paper and paperboard category is predicted to offer an incremental potential of US$ 21.9 billion by 2032, as well as a 6.6% CAGR throughout the projection period.
• With a market share of 25.1%, the folding cartons category now leads the industry.
• The pharma/biological pharmaceuticals area is the most profitable, accounting for an anticipated 53.4% of the market by 2032.
• During the projection period, the pharmaceutical secondary packaging sector in the United States is expected to exceed US$ 14,878.6 million.
• Throughout the projection period, Germany is expected to account for 15.3% of Europe’s pharmaceutical secondary packaging business.

Purchase this report to Uncover Segment-specific Information, Identify Key Trends, Drivers, and Challenges: https://www.futuremarketinsights.com/checkout/16614

Market Growth Factors

The escalating emphasis on product safety and traceability stands as a catalyst for the increased adoption of pharmaceutical secondary packaging. This surge is fueled by the need for packaging that shields drugs from contamination and tampering. Additionally, the implementation of e-pedigree systems is gaining traction, facilitating the meticulous tracking and tracing of drug movements within the supply chain.

As the prevalence of unit dose packaging in the pharmaceutical industry continues to rise, there is a corresponding surge in the acceptance of secondary packaging solutions. These solutions play a pivotal role in ensuring precise dosage administration and mitigating the risk of medication errors.

The burgeoning demand for packaging solutions that are child-resistant and senior-friendly is propelling the industry forward. These specialized packaging options are meticulously designed to thwart accidental drug ingestion by children and elderly individuals, thus contributing to the overall growth of the sector.

Recent Developments by Key Players:

• Gerresheimer AG and Stevanato Group have announced a collaboration to develop a new ready-to-use solution platform based on the EZ-fill® pre-sterilized platform in July 2022.
• Berry Global Group and Raw Elements USA cooperated to launch a sugarcane-based sustainable tube in January 2022. The tubes are made from waste sugarcane, which is converted into HDPE and LDPE to make a material with the same chemical composition as polyethylene obtained from fossil fuels.
• In June 2021, Amcor PLC launched the ACT2100 heat seal coating for use with medical-grade DuPont Tyvek2 and paper packaging. This innovative coating process improves the performance characteristics of medical applications.

Industry by Category

By Application:

• Pharma/ Biological Drug
• Veterinary Medicines
• Vaccine

By Material:

• Paper and Paperboard
• Plastics

By Packaging Format:

• Boxes
• Folding Cartons
• Blisters
• Bags and Pouch
• Trays
• Inserts and Dividers
• Wrapping Films

By End-use:

• Ophthalmic
• Injectable
• Biologics
• Wound Care
• Respiratory
• Therapy
• Oral

By Region:

• North America
• Latin America
• Europe
• South Asia and the Pacific
• East Asia
• Middle East and Africa

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer, Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani  

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube